Stock Option Plan (Tables)

12 Months Ended

Nov. 04, 2023

Share-Based Payment Arrangement [Abstract]

Options Granted

A summary of information with respect to options granted is as follows:

	Number of Shares		Stock Option Price Range		Weighted Average Exercise Price		Weighted Average Grant Date Fair Value
Outstanding at November 6, 2021		47,300	$ 12.10  - 25.75		$	24.41		—
Granted		20,400		33.10		33.10		—
Exercised		1,500		12.10		12.10		—
Canceled		—		—		—		—
Outstanding at November 5, 2022		66,200	$ 24.00  - 33.10		$	27.37	$	498,844
Granted		29,300		24.25		24.25	$	223,214
Exercised		—		—		—		—
Canceled		21,242	$ 24.00  - 33.10			26.21	$	156,905
Outstanding at November 4, 2023		74,258	$ 24.00  - 33.10		$	26.46	$	565,153

The aggregate intrinsic value of exercisable Company options was $33,752, and the aggregate intrinsic value of all outstanding in-the-money options was $169,798 at November 4, 2023, which is the difference between the Company’s closing stock price on the last trading day of fiscal year 2023 and the exercise price times the number of shares, that would have been received by the option holder had the option holder exercised their options on November 4, 2023.

Outstanding Stock Options

The following table summarizes information about the outstanding stock options at November 4, 2023:

Options Outstanding								Options Exercisable
Exercise Price		Shares Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	24.00		16,908		2	$	24.00		7,609	$	24.00
$	25.75		15,750		3		25.75		3,938		25.75
$	33.10		16,400		4		33.10		1,640		33.10
$	24.25		25,200		5		24.25		—		24.25
			74,258		3.67	$	26.46	$	13,187	$	26.46